Lucía Veiga López on Muck Rack

Lucía Veiga López

Madrid
As seen in: Color Research & Application, El País, Nature, Wiley Online Library, El Mundo, El Español, The New England Journal of Medicine, El Comercio, El Correo Gallego, El Mostrador and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lucía Veiga

Contact Lucía Veiga, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Synthesis of Spirolactones from Carbonyls via Carboborylation of N‐Sulfonylhydrazones with Alkoxycarbonylalkylboronic Acids

|
By Lucia Suarez Lopez, Lucía F. Lopez, Lucia I. López, Lucía Veiga López, Sara Filgueira, María-Paz Cabal, Carlos Valdes
| Wiley Online Library Verified
1 Introduction Spirocyclic molecules are highly valued in medicinal chemistry due to their unique structural characteristics. The rigid 3D structure imposed by the spirocycle can enhance the molecule binding affinity to biological targets.[1] In particular, the spirolactone moiety is a structural motif that can be found in a wide array of natural and unnatural compounds with biological activities.
Open in Who Shared Issue with article?

Synthesis of spirolactones from carbonyls via carboborylation of N‐sulfonylhydrazones with alkoxycarbonylalkylboronic acids

|
By Lucia Suarez Lopez, Lucía F. Lopez, Lucia I. López, Lucía Veiga López, María-Paz Cabal, Sara Filgueira, Alfonso Carlos Valdés-Gómez
| Wiley Online Library Verified
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Filename Description adsc202500170-s1-SI_1.pdf4.5 MB Supplementary
Open in Who Shared View Duplicates (593) Issue with article?

Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors - Nature Communications

|
By Lucia Alonso Lopez, Lucía F. Lopez, Lucia I. López, Lucía Veiga López, Luciano Gaston Morosi, Federica La Terza, Giuseppe Rospo, Francesca Giannese, Alberto Bardelli, Marc Dalod, Nicoletta Caronni, Pierre Guermonprez
| Nature Verified
Abstract Cross-presentation by type 1 DCs (cDC1) is critical to induce and sustain antitumoral CD8 T cell responses to model antigens, in various tumor settings. However, the impact of cross-presenting cDC1 and the potential of DC-based therapies in tumors carrying varied levels of bona-fide neoantigens (neoAgs) remain unclear.
Open in Who Shared Issue with article?
See all 483 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified